Compared to the miR-101 overexpression group, glioma cells co-expressing miR-101 and METTL3 exhibited enhanced proliferation (Fig. 7D), restored p62 protein levels, decreased LC3II expression (Fig. 7E), and suppressed autophagic flux (Fig. 7F). This evidence concerns the gene METTL3 and central nervous system cancer.